Zheng J - Search Results

1

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.

Ye G, Gallant JP, Massey C, Shi K, Tai W, Zheng J, Odle AE, Vickers MA, Shang J, Wan Y, Drelich A, Kempaiah KR, Tat V, Perlman S, Du L, Tseng CT, Aihara H, LeBeau AM, Li F. Ye G, et al. Among authors: zheng j. bioRxiv [Preprint]. 2020 Nov 17:2020.11.17.386532. doi: 10.1101/2020.11.17.386532. bioRxiv. 2020. PMID: 33236012 Free PMC article. Updated. Preprint.

2

Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.

Zheng J, Perlman S. Zheng J, et al. Curr Opin Virol. 2018 Feb;28:43-52. doi: 10.1016/j.coviro.2017.11.002. Epub 2017 Nov 21. Curr Opin Virol. 2018. PMID: 29172107 Free PMC article. Review.

3

K18-hACE2 Mice for Studies of COVID-19 Treatments and Pathogenesis Including Anosmia.

Zheng J, Roy Wong LY, Li K, Verma AK, Ortiz M, Wohlford-Lenane C, Leidinger MR, Knudson CM, Meyerholz DK, McCray PB, Perlman S. Zheng J, et al. bioRxiv [Preprint]. 2020 Aug 10:2020.08.07.242073. doi: 10.1101/2020.08.07.242073. bioRxiv. 2020. PMID: 32817939 Free PMC article. Updated. Preprint.

4

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.

Ye G, Gallant J, Zheng J, Massey C, Shi K, Tai W, Odle A, Vickers M, Shang J, Wan Y, Du L, Aihara H, Perlman S, LeBeau A, Li F. Ye G, et al. Among authors: zheng j. Elife. 2021 Aug 2;10:e64815. doi: 10.7554/eLife.64815. Elife. 2021. PMID: 34338634 Free PMC article.

5

Development of a Saliva-Optimized RT-LAMP Assay for SARS-CoV-2.

Yu AD, Galatsis K, Zheng J, Le JQ, Ma D, Perlman S, Rosbash M. Yu AD, et al. Among authors: zheng j. J Biomol Tech. 2021 Sep;32(3):102-113. doi: 10.7171/jbt.21-3203-005. J Biomol Tech. 2021. PMID: 35027868 Free PMC article.

6

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.

Shi J, Zheng J, Zhang X, Tai W, Odle AE, Perlman S, Du L. Shi J, et al. Among authors: zheng j. Transl Res. 2022 Oct;248:11-21. doi: 10.1016/j.trsl.2022.04.007. Epub 2022 Apr 28. Transl Res. 2022. PMID: 35489692 Free PMC article.

7

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.

Shi J, Zheng J, Tai W, Verma AK, Zhang X, Geng Q, Wang G, Guan X, Malisheni MM, Odle AE, Zhang W, Li F, Perlman S, Du L. Shi J, et al. Among authors: zheng j. J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16. J Virol. 2022. PMID: 35972290 Free PMC article.

8

SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice.

El-Kafrawy SA, Odle A, Abbas AT, Hassan AM, Abdel-Dayem UA, Qureshi AK, Wong LR, Zheng J, Meyerholz DK, Perlman S, Zumla A, Azhar EI. El-Kafrawy SA, et al. Among authors: zheng j. PLoS Pathog. 2022 Sep 19;18(9):e1010782. doi: 10.1371/journal.ppat.1010782. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36121829 Free PMC article.

9

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.

Shi J, Wang G, Zheng J, Verma AK, Guan X, Malisheni MM, Geng Q, Li F, Perlman S, Du L. Shi J, et al. Among authors: zheng j. NPJ Vaccines. 2022 Dec 19;7(1):169. doi: 10.1038/s41541-022-00580-z. NPJ Vaccines. 2022. PMID: 36535987 Free PMC article.

10

Prostaglandin D2 signaling in dendritic cells is critical for the development of EAE.

Zheng J, Sariol A, Meyerholz D, Zhang Q, Abrahante Lloréns JE, Narumiya S, Perlman S. Zheng J, et al. J Autoimmun. 2020 Nov;114:102508. doi: 10.1016/j.jaut.2020.102508. Epub 2020 Jul 2. J Autoimmun. 2020. PMID: 32624353 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22,155 results

Search Page